Skip to main content

Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.

Publication ,  Journal Article
Bafford, AC; Powers, S; Ha, C; Kruse, D; Gorfine, SR; Chessin, DB; Bauer, JJ
Published in: J Clin Gastroenterol
July 2013

GOALS: The aim of this study was to examine the impact of immunosuppressive therapy on the morbidity of intestinal surgery in patients with Crohn's disease. BACKGROUND: An increasing number of immunomodulating agents are being used in the treatment of Crohn's disease. The effect of these medications on surgical morbidity is controversial. STUDY: We performed a retrospective review of our prospectively maintained database of patients with Crohn's disease who underwent intestinal surgery between June 1999 and May 2010. The effect of perioperative immunomodulation on postoperative outcomes, specifically anastomotic complications, was evaluated. Predictors of postoperative morbidity among demographic and surgical variables were identified. Length of hospitalization and rate of hospital readmission were compared between groups. Comparisons were made using Student t test and Fisher exact test. RESULTS: One hundred ninety-six intestinal procedures were performed. One hundred twenty-seven (64.8%) of these were performed among patients who received perioperative immunomodulation. Forty-six (23.5%) procedures were in patients who received >1 immunomodulating medication perioperatively. Complications occurred in 45 (23.0%) cases. There were 20 (10.2%) anastomotic complications, including 8 (4.1%) intra-abdominal abscesses, 8 (4.1%) anastomotic leaks, and 4 (2%) enterocutaneous fistulas. Preoperative treatment with steroids (P=0.21), 6-MP (P=0.10), and anti-tumor necrosis factor biologics (P=1.0) was not associated with increased postoperative anastomotic complications. Combination immunosuppressive therapy also did not increase morbidity (P=0.39). CONCLUSIONS: In our series, single agent and combination immunosuppressive therapy given around the time of intestinal surgery did not increase the incidence of surgical complications in patients with Crohn's disease.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Gastroenterol

DOI

EISSN

1539-2031

Publication Date

July 2013

Volume

47

Issue

6

Start / End Page

491 / 495

Location

United States

Related Subject Headings

  • Young Adult
  • Retrospective Studies
  • Postoperative Complications
  • Middle Aged
  • Male
  • Immunosuppressive Agents
  • Immunosuppression Therapy
  • Humans
  • Gastroenterology & Hepatology
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bafford, A. C., Powers, S., Ha, C., Kruse, D., Gorfine, S. R., Chessin, D. B., & Bauer, J. J. (2013). Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease. J Clin Gastroenterol, 47(6), 491–495. https://doi.org/10.1097/MCG.0b013e3182677003
Bafford, Andrea C., Sarah Powers, Christina Ha, Danielle Kruse, Stephen R. Gorfine, David B. Chessin, and Joel J. Bauer. “Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.J Clin Gastroenterol 47, no. 6 (July 2013): 491–95. https://doi.org/10.1097/MCG.0b013e3182677003.
Bafford AC, Powers S, Ha C, Kruse D, Gorfine SR, Chessin DB, et al. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease. J Clin Gastroenterol. 2013 Jul;47(6):491–5.
Bafford, Andrea C., et al. “Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.J Clin Gastroenterol, vol. 47, no. 6, July 2013, pp. 491–95. Pubmed, doi:10.1097/MCG.0b013e3182677003.
Bafford AC, Powers S, Ha C, Kruse D, Gorfine SR, Chessin DB, Bauer JJ. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease. J Clin Gastroenterol. 2013 Jul;47(6):491–495.

Published In

J Clin Gastroenterol

DOI

EISSN

1539-2031

Publication Date

July 2013

Volume

47

Issue

6

Start / End Page

491 / 495

Location

United States

Related Subject Headings

  • Young Adult
  • Retrospective Studies
  • Postoperative Complications
  • Middle Aged
  • Male
  • Immunosuppressive Agents
  • Immunosuppression Therapy
  • Humans
  • Gastroenterology & Hepatology
  • Female